HROB as a novel prognostic biomarker associated with tumor immunity in clear cell renal cell carcinoma: A comprehensive analysis integrating bulk sequencing

Bibliographic Details
Published in:	Asian Journal of Surgery
Main Authors:	Guixin Ding, Fengze Sun, Ming Liu, Jitao Wu
Format:	Article
Language:	English
Published:	Elsevier 2025-04-01
Subjects:	HROB Tumor microenvironment ccRCC Biomarker
Online Access:	http://www.sciencedirect.com/science/article/pii/S1015958424024497

Similar Items

RGS19 is a novel prognostic biomarker for tumor immunity in clear cell renal cell carcinoma revealed through comprehensive bulk and single-cell sequencing analysis
by: Zhentao Lei, et al.
Published: (2025-03-01)

Unveiling FADS3 as a novel prognostic biomarker for tumor immunity in clear cell renal cell carcinoma through comprehensive RNA and single-cell sequencing
by: Zekun Xin, et al.
Published: (2025-04-01)

BOP1: A pivotal prognostic biomarker in clear cell renal cell carcinoma uncovered through integrated bulk and single-cell sequencing
by: Wenyu Wang, et al.
Published: (2025-04-01)

Metabolic reprogramming of clear cell renal cell carcinoma
by: Haiyan Zhu, et al.
Published: (2023-06-01)

ARRB2 as a potential prognostic biomarker associated with immune infiltration in clear cell renal cell carcinoma: Insights from integrated RNA and single-cell sequencing
by: Wenjun Meng, et al.
Published: (2025-08-01)

COLGALT1: A newly found prognostic biomarker for tumor immunity in ccRCC through comprehensive bulk and single-cell sequencing analysis
by: Yuanyuan Zhong, et al.
Published: (2025-06-01)

Identification of prognostic RNA editing profiles for clear cell renal carcinoma
by: Weihong Chen, et al.
Published: (2024-07-01)

PLAC8 is an innovative biomarker for immunotherapy participating in remodeling the immune microenvironment of renal clear cell carcinoma
by: Xu Sun, et al.
Published: (2023-10-01)

CEBPB as a prognostic biomarker and its association with immune cells in clear cell renal cell carcinoma
by: Yaoqiang Ren, et al.
Published: (2025-12-01)

Identification of CENPW as a prognostic biomarker and potential therapeutic target for clear cell renal cell carcinoma
by: Haibing Xiao, et al.
Published: (2025-06-01)

Development and verification of a novel risk model related to ubiquitination linked with prognosis and therapeutic response in clear cell renal cell carcinoma
by: Yingzhi Chen, et al.
Published: (2024-10-01)

Developing hypoxia and lactate metabolism-related molecular subtypes and prognostic signature for clear cell renal cell carcinoma through integrating machine learning
by: Jinhui Liu, et al.
Published: (2024-11-01)

Roles of cathepsin S expression levels on the prognosis and tumour microenvironment in clear cell renal cell carcinoma
by: Xiang Wang, et al.
Published: (2024-11-01)

Prognostic significance of systemic immunoinflammatory biomarkers in patients with clear cell renal cell carcinoma: a retrospective multicenter analysis
by: Danlei Chen, et al.
Published: (2025-08-01)

OASL as a novel prognostic biomarker associated with immune infiltrates in ccRCC
by: Zekun Xin, et al.
Published: (2025-08-01)

AURKB: a promising biomarker in clear cell renal cell carcinoma
by: Bangbei Wan, et al.
Published: (2019-09-01)

Identification of ferroptosis-related gene signatures as a novel prognostic model for clear cell renal cell carcinoma
by: Xiaoxiao Du, et al.
Published: (2025-04-01)

SERPINE1 and its co-expressed genes are associated with the progression of clear cell renal cell carcinoma
by: Lingyu Guo, et al.
Published: (2023-03-01)

ZBP1 as a prognostic biomarker correlated with cell proliferation in clear cell renal cell carcinoma
by: Yuqing Zhang, et al.
Published: (2024-10-01)

A novel prognostic signature for clear cell renal cell carcinoma constructed using necroptosis-related miRNAs
by: Zuhu Yu, et al.
Published: (2023-03-01)

Comprehensive Analysis of the Butyrate-Metabolism-Related Gene Signature in Tumor Microenvironment-Infiltrating Immune Cells in Clear Cell Renal Cell Carcinoma
by: Gang Tang, et al.
Published: (2022-05-01)

Comprehensive analysis of a homeobox family gene signature in clear cell renal cell carcinoma with regard to prognosis and immune significance
by: Di Zheng, et al.
Published: (2022-10-01)

FBXO6 as a potential prognostic biomarker linked to immune infiltration in ccRCC based on integrated RNA and single-cell sequencing analysis
by: Zekun Xin, et al.
Published: (2025-09-01)

Cancer-Associated Fibroblast-Derived FGF7 Promotes Clear Cell Renal Cell Carcinoma Progression and Macrophage Infiltration
by: Man Jia, et al.
Published: (2024-11-01)

KL is a favorable prognostic factor related immune for clear cell renal cell carcinoma
by: Ke-Hao Pan, et al.
Published: (2023-09-01)

Cyclin-dependent kinase 5 acts as a promising biomarker in clear cell Renal Cell Carcinoma
by: Liangsong Zhu, et al.
Published: (2019-07-01)

STEAP3 can predict the prognosis and shape the tumor microenvironment of clear cell renal cell carcinoma
by: Jiyue Wu, et al.
Published: (2022-11-01)

Exploring the prognostic implications of cuproptosis-associated alterations in clear cell renal cell carcinoma via in vitro experiments
by: Zhaoyu Xing, et al.
Published: (2024-07-01)

MDK promotes M2 macrophage polarization to remodel the tumour microenvironment in clear cell renal cell carcinoma
by: Naipeng Shi, et al.
Published: (2024-08-01)

CD2AP is a potential prognostic biomarker of renal clear cell carcinoma
by: Can Chen, et al.
Published: (2024-02-01)

Establishment and validation of a polygene prognostic model for clear cell renal cell carcinoma
by: Kai Gan, et al.
Published: (2022-10-01)

FXR promotes clear cell renal cell carcinoma carcinogenesis via MMP-7-regulated EMT pathway
by: Jiachen Liu, et al.
Published: (2024-11-01)

High expression level of MMP9 is associated with poor prognosis in patients with clear cell renal carcinoma
by: Haitao Niu, et al.
Published: (2018-07-01)

ARHGAP9 may be used as a novel prognostic biomarker associated with tumor immunity and cellular composition in ccRCC
by: Yini Wang, et al.
Published: (2025-05-01)

Association of HLA-DRA expression with prognosis and tumor microenvironment in clear cell renal cell carcinoma
by: Shu-Xin Qu, et al.
Published: (2025-08-01)

Identification of a three-m6A related gene risk score model as a potential prognostic biomarker in clear cell renal cell carcinoma
by: Yiqiao Zhao, et al.
Published: (2020-03-01)

Comprehensive investigation into cuproptosis in the characterization of clinical features, molecular characteristics, and immune situations of clear cell renal cell carcinoma
by: Bao Wang, et al.
Published: (2022-10-01)

A novel necroptosis-related long noncoding RNA model for predicting clinical features, immune characteristics, and therapeutic response in clear cell renal cell carcinoma
by: Lei Zhang, et al.
Published: (2023-08-01)

Cuprotosis-related signature predicts overall survival in clear cell renal cell carcinoma
by: Fan Zhang, et al.
Published: (2022-09-01)

The effect of PDLIM7 on cell proliferation, migration, and drug sensitivity in clear cell renal cell carcinoma
by: Chong Shen, et al.
Published: (2025-07-01)